Sato Clear Dailymed
Generic: naphazoline hydrochloride is used for the treatment of Hyperemia Rhinitis Sinusitis Glaucoma, Angle-Closure
Go PRO for all pill images
Otc - Active Ingredient Section
Active ingredient Naphazoline hydrochloride 0.012%
Otc - Purpose Section
Purpose Naphazoline hydrochloride    Vasoconstrictor
Indications & Usage Section
Uses relieves this symptom due to minor eye irritations â– redness of the eye
Warnings Section
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use
- if solution changes color or becomes cloudy
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- narrow angle glaucoma
OTC - WHEN USING SECTION
When using this product
- pupils may become enlarged temporarily
- overuse of this product may produce increased redness of the eyes
- to avoid contamination, do not touch tip of container to any surface
- replace cap after using
OTC - STOP USE SECTION
Stop use and ask a doctor if you experience
- eye pain
- changes in vision
- continued redness or irritation of the eye
- the condition worsens or persists for more than 72 hours
Otc - Keep Out Of Reach Of Children Section
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Dosage & Administration Section
Directions â– Place 1 or 2 drops in the affected eyes up to 4 times daily.
Other Safety Information
Other information
- use only if imprinted tamper-resistant seal on the bottle cap is intact
- keep container tightly closed Â
Inactive Ingredient Section
Inactive ingredients benzalkonium chloride, boric acid, dl-camphor, sodium borate, sodium chloride, purified water.
Package Label.principal Display Panel
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
